In the last trading session, 67526.0 shares of the Apyx Medical Corp (NASDAQ:APYX) were traded, and its beta was 1.21. Most recently the company’s share price was $1.54, and it changed around -$0.12 or -7.23% from the last close, which brings the market valuation of the company to $58.20M. APYX currently trades at a discount to its 52-week high of $1.95, offering almost -26.62% off that amount. The share price’s 52-week low was $0.76, which indicates that the current value has risen by an impressive 50.65% since then.
Apyx Medical Corp stock received a consensus recommendation rating of Hold, based on a mean score of 2.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 2 recommended APYX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Apyx Medical Corp is expected to report earnings per share of -0.09 for the current quarter.
Apyx Medical Corp (NASDAQ:APYX) trade information
Instantly APYX has showed a red trend with a performance of -7.23% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7254 on recent trading dayincreased the stock’s daily price by 10.75%. The company’s shares are currently down -2.53% year-to-date, but still up 7.69% over the last five days. On the other hand, Apyx Medical Corp (NASDAQ:APYX) is 69.31% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $8.5, which translates to bulls needing to increase their stock price by 81.88% from its current value. Analyst projections state that APYX is forecast to be at a low of $5 and a high of $12.
Apyx Medical Corp (APYX) estimates and forecasts
The year-over-year growth rate is expected to be 0.26%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 11.69M in revenue for the current quarter. 3 analysts expect Apyx Medical Corp to make 11.72M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 12.15M and 11.49M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -3.81%. Forecasts for the next quarter put sales growth at 2.04%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.68%. Apyx Medical Corp earnings are expected to increase by 41.85% in 2025, but the outlook is positive 20.65% per year for the next five years.
APYX Dividends
Apyx Medical Corp’s next quarterly earnings report is expected to be released in June.
ROYCE & ASSOCIATES LP, with 7.2082% or 2.5 million shares worth $3.35 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and ROYCE FUND-Royce Small-Cap Opportunity Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.01 shares worth $1.56 million, making up 2.67% of all outstanding shares. On the other hand, ROYCE FUND-Royce Small-Cap Opportunity Fund held roughly 916.13 shares worth around $1.41 million, which represents about 2.42% of the total shares outstanding.
